Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 4Head & Neck 1Genitourinary 1Endocrine 1

Conditions

Thyroid Cancer, Papillary 2Adenocarcinoma, Follicular 2Testicular Neoplasms 1Non-resectable Metastatic Cancer of the Lung 1Melanoma 1

Interventions

Nivolumab 2Bortezomib 2vatalanib 1tovorafenib 1tipifarnib 1spartalizumab 1sargramostim 1romidepsin 1pentetreotide 1pasireotide 1milademetan 1fludarabine phosphate 1entrectinib 1entinostat 1dabrafenib 1cobimetinib 1avelumab 1alectinib 1aldesleukin 1Vemurafenib 1Taxes 1Specimen Handling 1Rose Bengal 1Quality of Life 1Patient Reported Outcome Measures 1Paclitaxel 1PLX8394 1Molecular Diagnostic Techniques 1Microscopy, Electron 1Melphalan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Melanoma × Interviews as Topic × Endocrine × Clear all
NCT07529080 2026-04-14

Personalized Cancer Support (Thrive Track) to Manage the Emotional Needs of Young Adults With Thyroid, Melanoma and Testicular Cancer, PerCS-YA Trial

University of Michigan Rogel Cancer Center

Phase NA Not yet recruiting
142 enrolled
DermatologicEndocrineGenitourinaryHead & Neck

Thyroid Cancer, Papillary, Melanoma, Testicular Neoplasms, Adenocarcinoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡